proqolid

Home > Instruments > Expanded Prostate Cancer Index Composite (EPIC)

INSTRUMENT DETAILS

Expanded Prostate Cancer Index Composite (EPIC)

 
The Epic (developed in 2000) is a modified expansion of the UCLA-PCI
 

Author(s)

Dunn Rodney L, MS; Litwin Mark S, MD, MPH; Sanda Martin G, MD; Sandler HM; Wei John T, MD

 

Purpose

  • Pathology:

Male genital diseases

Neoplasms

  • Disease:

Genital neoplasms, Male

  • Objective:

For comprehensive assessment of health-related quality of life in men with prostate cancer

  • Population for intended use:

Male

 
 

Characteristics

  • Type of instrument:

Health-Related Quality of Life - HRQL (incl. health status)

  • Administration mode:

Self-administered

  • Number of items:

50

  • Recall/Observation period:

During the last four weeks

 
 

Language(s)

  • Original language:

English for the USA

  • List of existing translations:

The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.

EPIC

Dutch for the Netherlands
Japanese for Japan
 

Bibliographic reference(s) of the original questionnaire

Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG. A comprehensive comparison of health related quality of life following contemporary therapies for localized prostate cancer. Journal of Clinical Oncology, 20 (2): 557-566, 2002 (Full text article)


Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000; 56: 899-905 (Full text article)

Last update: July 2009

Last update in collaboration with the author: March 2008